We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+5.11%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$4.21B
AUM Growth
+$1.09B
Cap. Flow
+$955M
Cap. Flow %
22.68%
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 17.98%
2 Industrials 11.87%
3 Financials 10.81%
4 Healthcare 9.53%
5 Consumer Discretionary 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDS icon
676
ProShares UltraShort S&P500
SDS
$421M
$134K ﹤0.01%
500
MTNB icon
677
Matinas BioPharma
MTNB
$1.86M
$129K ﹤0.01%
+2,460
New +$165K
EVM
678
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
$123K ﹤0.01%
10,532
ORGS
679
DELISTED
Orgenesis Inc. Common Stock
ORGS
$115K ﹤0.01%
2,000
IVC
680
DELISTED
Invacare Corporation
IVC
$112K ﹤0.01%
13,988
PIPP
681
DELISTED
Pine Island Acquisition Corp.
PIPP
$100K ﹤0.01%
+10,000
New +$115K
KRRO icon
682
Korro Bio
KRRO
$150M
$95K ﹤0.01%
200
PNNT
683
Pennant Park Investment Corp
PNNT
$221M
$88K ﹤0.01%
15,590
-860
-5% -$4.7K
NOK icon
684
Nokia
NOK
$49.3B
$75K ﹤0.01%
+19,016
New +$79.4K
FSP
685
Franklin Street Properties
FSP
$48.2M
$67K ﹤0.01%
+12,282
New +$61.2K
LAB icon
686
Standard BioTools
LAB
$305M
$55K ﹤0.01%
12,100
+100
+0.8% +$549
GGN
687
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$761M
$49K ﹤0.01%
+14,232
New +$49.8K
BRMK.WS
688
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$49K ﹤0.01%
213,500
-235,648
-52% -$59.1K
CATX icon
689
Perspective Therapeutics
CATX
$323M
$44K ﹤0.01%
4,000
RIGL icon
690
Rigel Pharmaceuticals
RIGL
$692M
$42K ﹤0.01%
+1,230
New +$48.7K
LYG icon
691
Lloyds Banking Group
LYG
$86.9B
$30K ﹤0.01%
12,717
-3,569
-22% -$7.41K
CSCI
692
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$23K ﹤0.01%
+200
New +$22.2K
TNXP icon
693
Tonix Pharmaceuticals
TNXP
$165M
0
ACWX icon
694
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
-20,714
Closed -$1.1M
ATR icon
695
AptarGroup
ATR
$8.74B
-2,052
Closed -$281K
BBCA icon
696
JPMorgan BetaBuilders Canada ETF
BBCA
$11B
-5,929
Closed -$318K
BBJP icon
697
JPMorgan BetaBuilders Japan ETF
BBJP
$17.1B
-6,337
Closed -$355K
BGB
698
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
-15,331
Closed -$191K
BHR
699
Braemar Hotels & Resorts
BHR
$157M
-41,912
Closed -$193K
BIIB icon
700
Biogen
BIIB
$29.9B
-1,129
Closed -$277K

Similar funds

Cerity Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Cerity Partners held 765 positions worth $4.21B, up 35% from $3.12B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Cerity Partners deployed $955M of net new capital in Q1 2021, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was Allogene Therapeutics: 401,602 shares worth $14.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Caterpillar, an estimated $8.11M trimmed.

  • Cerity Partners's largest Q1 2021 buy was Allogene Therapeutics: 401,602 shares worth $14.2M.
  • Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $110M increase.
  • Cerity Partners's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $8.11M.
  • Cerity Partners fully exited Cantel Medical Corporation in Q1 2021, selling an estimated $15.9M.
  • Cerity Partners's ten largest holdings make up 34% of its $4.21B portfolio in Q1 2021.
  • Cerity Partners opened 125 new positions and closed 72 in Q1 2021.
  • Cerity Partners's portfolio value rose 35% quarter-over-quarter to $4.21B.

Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.